9363702

Ciampelli M

1997

Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome.

9363711

Tadokoro N

1997

Cumulative pregnancy rates in couples with anovulatory infertility compared with unexplained infertility in an ovulation induction programme.

9364254

Lupoli G

1997

Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass.

9369189

Lambert-Messerlian G

1997

Characterization of intrafollicular steroid hormones, inhibin, and follistatin in women with and without polycystic ovarian syndrome following gonadotropin hyperstimulation.

9385529

Takeuchi T

1997

Effect of growth hormone suppression on the serum levels of ovarian and adrenal sex steroid hormones in normal women and in women with polycystic ovary syndrome.

9385530

Mici? D

1997

Leptin levels and insulin sensitivity in obese and non-obese patients with polycystic ovary syndrome.

9396280

Tsutsumi O

1997

[Abnormal female reproductive function].

9396305

Kitaoka Y

1997

[Polycystic ovary syndrome: PCOS].

9398716

Nestler JE

1997

Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens.

9403321

Nestler JE

1997

Insulin regulation of human ovarian androgens.

9403322

Scheen AJ

1997

Perspective in the treatment of insulin resistance.

9403323

Lefebvre P

1997

Influences of weight, body fat patterning and nutrition on the management of PCOS.

9403324

Pasquali R

1997

Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome.

9403325

Galtier-Dereure F

1997

Choice of stimulation in polycystic ovarian syndrome: the influence of obesity.

9404439

Rosenfield RL

1997

Is polycystic ovary syndrome a neuroendocrine or an ovarian disorder?

9408743

Dunaif A

1997

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

9410809

Mason M

1997

[The proportion of molecular forms of gonadotropins changes in patients with polycystic ovaries].

9413805

Murialdo G

1997

Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy.

9414438

Franks S

1996

Nutrition, insulin and polycystic ovary syndrome.

9418684

Tropeano G

1997

Effects of oral glucose administration on plasma growth hormone levels in women with polycystic ovary syndrome.

9419751

Schriock ED

1994

Enhanced post-receptor insulin effects in women following dehydroepiandrosterone infusion.

9420860

Palumbo A

1995

Apoptosis as a basic mechanism in the ovarian cycle: follicular atresia and luteal regression.

9420861

Diamanti-Kandarakis E

1995

Androgens and therapeutic aspects of antiandrogens in women.

9420884

Carmina E

1995

Altered regulation of insulin-like growth factor binding protein-1 in patients with polycystic ovary syndrome.

9425584

Sharma S

1997

Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate.

9429701

Liddell HS

1997

Recurrent miscarriage: screening for polycystic ovaries and subsequent pregnancy outcome.

9429864

Goudas VT

1997

Polycystic ovary syndrome.

9433961

Balen A

1997

Anovulatory infertility and ovulation induction. Policy and Practice subcommittee of the British Fertility Society.

9435423

De Leo V

1998

Hormonal effects of flutamide in young women with polycystic ovary syndrome.

9436663

Damario MA

1997

Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.

9436665

Kaaijk EM

1997

Unilateral oophorectomy in polycystic ovary syndrome: a treatment option in highly selected cases?

9436687

Lin Y

1997

Insulin stimulation of lactate accumulation in isolated human granulosa-luteal cells: a comparison between normal and polycystic ovaries.

9437235

Sahin Y

1997

The frequency of late-onset 21-hydroxylase and 11 beta-hydroxylase deficiency in women with polycystic ovary syndrome.

9437670

Marantides D

1997

Management of polycystic ovary syndrome.

9438919

Ruiz A

1997

Serum levels of GH, IGF-I, LH and ovarian steroids in cyclic and RU486-treated rats.

9440305

Ch?vez-Ross A

1997

Modelling the control of ovulation and polycystic ovary syndrome.

9441866

Witchel SF

1997

Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency.

9444888

Irwin M

1998

Valproate and polycystic ovaries.

9447454

Vrtacnik-Bokal E

1997

Short-term GnRH-analogue administration in patients with PCOS and its impact on hemodynamics and hormonal profile.

9451521

Lunenfeld B

1997

An overview of obesity during puberty, adolescence and reproduction.

9452898

Slupik RI

1998

Case studies in contraception.

9452956

Bertschy S

1998

Selective immunocytochemical localisation of calretinin in the human ovary.

9454393

Ovesen PG

1998

[Polycystic ovary syndrome I. Clinical presentation and treatment].

9454394

Ovesen PG

1998

[Polycystic ovary syndrome II. Endocrinology and metabolism].

9455828

Franks S

1997

The genetic basis of polycystic ovary syndrome.

9457128

Edozien L

1998

Length of gestation and polycystic ovaries in adulthood.

9457129

van Hooff MH

1998

Length of gestation and polycystic ovaries in adulthood.

9457942

Liao WX

1998

A new molecular variant of luteinizing hormone associated with female infertility.

9459090

Tulandi T

1997

Reproductive performance and three-dimensional ultrasound volume determination of polycystic ovaries following laparoscopic ovarian drilling.

9463180

Falsetti L

1997

[Finasteride and flutamide in the treatment of hirsutism].

9467551

Van Der Meer M

1998

Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome.

9467578

Pastor CL

1998

Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.

9471896

Nalbanski B

1997

[Laparoscopic fenestration of the ovaries].

9472960

Invitti C

1998

Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome.

9472963

Fulghesu AM

1998

Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease.

9475386

Lee GY

1998

Multidrug resistance gene expression correlates with progesterone production in dehydroepiandrosterone-induced polycystic and equine chorionic gonadotropin-stimulated ovaries of prepubertal rats.

9477644

Z?rate A

1997

[Use of metformin in the management of adolescents with polycystic ovary syndrome].

9480574

Spremovi?-Radjenovi? S

1997

[The polycystic ovary syndrome associated with ovarian tumor].

9481555

de Vries MJ

1998

Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study.

9488580

Pelosi MA

1998

Simultaneous laparoscopic surgical treatments.

9489102

Salzmann J

1997

Central retinal vein occlusion associated with the polycystic ovarian syndrome.

9490171

Kreze A Jr

1997

[The polycystic ovary syndrome and insulin resistance].

9490599

Schlechte JA

1998

Update in endocrinology.

9492722

Bergh C

1998

Results of gonadotrophin stimulation with the option to convert cycles to in vitro fertilization in cases of multifollicular development.

9496335

Atiomo WU

1998

The plasminogen activator system in women with polycystic ovary syndrome.

9496351

Duleba AJ

1998

Insulin and insulin-like growth factor I stimulate the proliferation of human ovarian theca-interstitial cells.

9502773

Pincus SM

1998

Follicle-stimulating hormone is secreted more irregularly than luteinizing hormone in both humans and sheep.

9509072

Klinger B

1998

Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome.

9510005

Jakimiuk AJ

1998

Aromatase mRNA expression in individual follicles from polycystic ovaries.

9512218

van Montfrans JM

1998

Treatment of hyperinsulinaemia in polycystic ovary syndrome?

9512222

Kaltsas T

1998

Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome.

9529684

Young R

1998

Hirsutes. I: Diagnosis.

9532832

Gregorini SD

1997

[Endometrial carcinoma with polycystic ovaries. Report of two cases in women younger than 40 years old].

9532997

Li TC

1998

Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility.

9536211

Mason H

1997

Local control of ovarian steroidogenesis.

9536213

Rosenfield RL

1997

Current concepts of polycystic ovary syndrome.

9536214

Ehrmann DA

1997

Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus.

9536215

Dewailly D

1997

Definition and significance of polycystic ovaries.

9536216

Barnes RB

1997

Diagnosis and therapy of hyperandrogenism.

9539295

Pasquali R

1998

Insulin sensitizing agents and polycystic ovary syndrome.

9539300

Diamanti-Kandarakis E

1998

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome.

9542361

Lin KC

1998

Characterization of pulsatile secretion of gonadotropin and prolactin in women with normal menstrual cycle, secondary amenorrhea and polycystic ovary syndrome (PCOS).

9543131

Holte J

1998

High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus.

9546324

Isoj?rvi JI

1998

Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.

9548158

Okon MA

1998

Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function.

9548159

Morin-Papunen LC

1998

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

9548160

Gj?nnaess H

1998

Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome.

9549840

Lees C

1998

Unexpected effect of a nitric oxide donor on uterine artery Doppler velocimetry in oligomenorrheic women with polycystic ovaries.

9551368

Udoff LC

1996

Polycystic ovarian disease: current insights into an old problem.

9557226

Henze C

1998

Incidence of increased androgen levels in patients suffering from acne.

9557824

Doldi N

1998

Polycystic ovary syndrome: anomalies in progesterone production.

9564642

Erg?r AR

1998

Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.

9565144

Vegetti W

1998

Ovarian stimulation with low-dose pure follicle-stimulating hormone in polycystic ovarian syndrome anovulatory patients: effect of long-term pretreatment with gonadotrophin-releasing hormone analogue.

9565843

Lessey BA

1998

Embryo quality and endometrial receptivity: lessons learned from the ART experience.

9572406

Gennarelli G

1998

Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?

9572407

Paradisi G

1998

Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy.

9572412

Dale PO

1998

The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.

9572428

Agrawal R

1998

Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.

9578510

Falsetti L

1998

Serum levels of 3alpha-androstanediol glucuronide in hirsute and non hirsute women.

9579228

Adami S

1998

Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women.